Location · Wyoming, MI
Clinical trials in Wyoming, MI
16 recruiting studies have a site in Wyoming, and 0 of them accept healthy volunteers.
16 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Wyoming, MI + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Wyoming, MI + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Wyoming, MI + 118 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Eli Lilly and Company
- Location
- Wyoming, MI + 11 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Janus II Feasibility
Zoll Medical Corporation
- Location
- Wyoming, MI + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Wyoming, MI + 126 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Wyoming, MI + 77 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
AbbVie
- Location
- Wyoming, MI + 60 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Wyoming, MI + 36 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Wyoming, MI + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sanofi
- Location
- Wyoming, MI + 18 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Boehringer Ingelheim
- Location
- Wyoming, MI + 123 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Eli Lilly and Company
- Location
- Wyoming, MI + 38 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Eli Lilly and Company
- Location
- Wyoming, MI + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Wyoming, MI + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingEarly Phase 1
VTP-1000 in Adults With Celiac Disease
Barinthus Biotherapeutics
- Location
- Wyoming, MI + 15 other US sites
- Eligibility basics
- Ages 18–70